BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 3156377)

  • 1. Altered Cro repressors from engineered mutagenesis of a synthetic cro gene.
    Eisenbeis SJ; Nasoff MS; Noble SA; Bracco LP; Dodds DR; Caruthers MH
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1084-8. PubMed ID: 3156377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1H NMR study of the interaction of bacteriophage lambda Cro protein with the OR3 operator. Evidence for a change of the conformation of the OR3 operator on binding.
    Kirpichnikov MP; Hahn KD; Buck F; Rüterjans H; Chernov BK; Kurochkin AV; Skryabin KG; Bayev AA
    Nucleic Acids Res; 1984 Apr; 12(8):3551-61. PubMed ID: 6233535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How lambda repressor and lambda Cro distinguish between OR1 and OR3.
    Hochschild A; Douhan J; Ptashne M
    Cell; 1986 Dec; 47(5):807-16. PubMed ID: 2946418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lambda cro repressor complex with OR3 operator DNA. 19F nuclear magnetic resonance observations.
    Metzler WJ; Lu P
    J Mol Biol; 1989 Jan; 205(1):149-64. PubMed ID: 2522553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable, monomeric variants of lambda Cro obtained by insertion of a designed beta-hairpin sequence.
    Mossing MC; Sauer RT
    Science; 1990 Dec; 250(4988):1712-5. PubMed ID: 2148648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-DNA recognition.
    Pabo CO; Sauer RT
    Annu Rev Biochem; 1984; 53():293-321. PubMed ID: 6236744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of the interaction between lambda cro repressor protein and operator DNA fragments.
    Lee SJ; Shirakawa M; Akutsu H; Kyogoku Y; Shiraishi M; Kitano M; Shin M; Ohtsuka E; Ikehara M
    Nucleic Acids Symp Ser; 1985; (16):33-6. PubMed ID: 2935788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1H NMR study of the interaction of bacteriophage lambda Cro protein with the OR3 operator. II. Assignment of the non-exchangeable proton resonances of the OR3 operator.
    Hahn KD; Buck F; Rüterjans H; Chernov BK; Skryabin KG; Kirpichnikov MP
    Eur Biophys J; 1985; 12(2):87-95. PubMed ID: 3160577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of lambda cro repressor with synthetic operator OR3 studied by competition binding with minor groove binders.
    Gursky GV; Surovaya AN; Kurochkin AV; Chernov BK; Volkov SK; Kirpichnikov MP
    J Biomol Struct Dyn; 1992 Aug; 10(1):15-33. PubMed ID: 1329842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [C1 and cro repressors of lambda phages. I. Construction of vectors for expression of cro repressor of bacteriophage lambda imm434].
    Bespalova IN; Rubtsov PM; Kirpichnikov MP; Skriabin KG
    Mol Biol (Mosk); 1984; 18(1):30-8. PubMed ID: 6323976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriophage lambda cro mutations: effects on activity and intracellular degradation.
    Pakula AA; Young VB; Sauer RT
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):8829-33. PubMed ID: 2947238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential recognition of OR1 and OR3 by bacteriophage 434 repressor and Cro.
    Koudelka GB; Lam CY
    J Biol Chem; 1993 Nov; 268(32):23812-7. PubMed ID: 8226917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of cro-beta-galactosidase fusion proteins under the control of the PR promoter of bacteriophage lambda.
    Zabeau M; Stanley KK
    EMBO J; 1982; 1(10):1217-24. PubMed ID: 6327257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An NMR study on the structure of OR3 in the lambda cro-OR3 complex.
    Lee SJ; Shirakawa M; Yamamoto K; Akutsu H; Kyogoku Y; Kitano K; Shiraishi S; Shin M; Ohtsuka E; Ikehara M
    Nucleic Acids Symp Ser; 1986; (17):223-6. PubMed ID: 2951657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of the 26-39 fragment of the cro protein from lambda bacteriophage with nucleic acids.
    Mayer R; Lancelot G; Hélène C
    FEBS Lett; 1983 Mar; 153(2):339-44. PubMed ID: 6225680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lac repressor with the helix-turn-helix motif of lambda cro binds to lac operator.
    Kolkhof P; Teichmann D; Kisters-Woike B; von Wilcken-Bergmann B; Müller-Hill B
    EMBO J; 1992 Aug; 11(8):3031-8. PubMed ID: 1386307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage lambda Cro protein and cI repressor use two different patterns of specific protein-DNA interactions to achieve sequence specificity in vivo.
    Benson N; Youderian P
    Genetics; 1989 Jan; 121(1):5-12. PubMed ID: 2521838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Specificity of binding of regulatory proteins with DNA: possible explanation in terms of "point" interactions].
    Gul'tiaev AP; Zheltovskiĭ NV
    Mol Biol (Mosk); 1986; 20(3):827-37. PubMed ID: 2941680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of bacteriophage lambda repressor synthesis directed by the PRE promoter: influence of temperature, multiplicity of infection, and mutation of PRM or the cro gene.
    Yen KM; Gussin GN
    Mol Gen Genet; 1980; 179(2):409-19. PubMed ID: 6450868
    [No Abstract]   [Full Text] [Related]  

  • 20. cI and lexA repressors consist of three cro-like domains.
    Ptitsyn OB; Finkelstein AV; Kirpichnikov MP; Skryabin KG
    FEBS Lett; 1982 Oct; 147(1):11-5. PubMed ID: 6216121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.